INIS
patients
100%
cancer
81%
tumors
70%
carcinomas
42%
breasts
29%
diseases
26%
tissues
26%
humans
24%
risks
22%
surgery
19%
values
19%
therapy
17%
comparative evaluations
17%
metastases
17%
genes
15%
lymph nodes
15%
biological markers
14%
biopsy
14%
detection
13%
data
13%
reviews
13%
receptors
12%
kidneys
12%
inflammation
12%
women
11%
levels
11%
netherlands
11%
classification
11%
nmr imaging
11%
death
10%
proteins
10%
learning
9%
assessments
9%
pathology
9%
lymphocytes
9%
genetics
9%
dna
8%
ovaries
8%
chemotherapy
8%
populations
8%
neoplasms
8%
control
8%
mutations
7%
evaluation
7%
glioblastomas
7%
lungs
7%
autopsy
7%
growth
7%
images
6%
adenocarcinomas
6%
rna
6%
prediction
6%
adults
5%
validation
5%
correlations
5%
estrogens
5%
positron computed tomography
5%
females
5%
fibrosis
5%
bones
5%
mass spectrometry
5%
density
5%
Medicine and Dentistry
Neoplasm
40%
Breast Cancer
20%
Diseases
12%
Biological Marker
10%
Overall Survival
9%
Immunohistochemistry
9%
Magnetic Resonance Imaging
9%
Colorectal Carcinoma
9%
Biopsy Technique
9%
Malignant Neoplasm
8%
Pathologist
8%
Cohort Analysis
7%
Recurrent Disease
7%
Lymph Node
7%
Intraductal Carcinoma
6%
Systemic Therapy
6%
Abdominal Cancer
6%
Basal-Cell Carcinoma
5%
Metastatic Carcinoma
5%
Wart Virus
5%
Tumor Infiltrating Lymphocyte
5%
Keyphrases
Tumor
20%
Netherlands
12%
Colorectal Cancer
11%
Immunohistochemistry
10%
Pathologist
9%
Overall Survival
8%
Prognostic Value
8%
Breast Cancer Patients
7%
Deep Learning
7%
Gastric Cancer
7%
Tumor-infiltrating Lymphocytes
6%
Breast Cancer
6%
Autopsy
5%
Dutch
5%
Confidence Interval
5%
High-risk Human Papillomavirus (HR-HPV)
5%
Basal Cell Carcinoma
5%
Ductal Carcinoma in Situ
5%
Neoadjuvant Systemic Therapy
5%
Pulmonary Carcinoid
5%
Warburg
5%